Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea

The aim of this study is to examine the prevalence of the Metabolic syndrome(MetS) in Korean patients with schizophrenia.

Primary objective:

• To investigate the prevalence of the MetS in Korean patients with schizophrenia

Secondary objectives:

• To compare the prevalence of the MetS among 3 groups according to antipsychotics: typical antipsychotic monotherapy group, atypical antipsychotic monotherapy group, 2 or more antipsychotics group (polypharmacy)

Inclusion Criteria:

• Diagnosis of schizophrenia according to DSM-IV-TR
• Age between 18-65 years